ArriVent BioPharma AVBP Ratios (2023-2026)

NASDAQ AVBP
$29.54 +0.24 (+0.82%)
At close: Sep 29, 2026 · 4:00 PM EDT
Reported Financials

ArriVent BioPharma Quarterly Ratios

Periods 13 quarters
Latest Jun 2026

ArriVent BioPharma ratios data for the quarter ended Jun 2026. These financial ratios cover 13 quarters of results from Jun 2023 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Ratios Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Efficiency
Assets AverageAssets Avg. 245.47M318.35M300.78M283.83M245.22M242.50M298.03M329.86M341.23M372.01M
Equity AverageEquity Avg. -107.77M-125.53M-142.90M82.27M307.19M287.08M267.57M230.10M226.21M277.43M306.11M315.60M345.41M
Valuation
Price to BookP/B 1.412.102.853.493.113.272.472.783.234.58
Enterprise Value 129.93M322.89M508.92M679.09M453.34M580.48M453.46M541.32M718.90M1,305.50M
Market Capitalization 447.33M621.59M791.82M897.95M629.42M816.17M753.73M854.14M1,045.28M1,678.62M
Return Ratios
Return on Capital Employed [ROCE]ROCE -35.28%-28.15%-32.81%-35.38%-60.45%-66.56%-58.75%-58.42%-49.61%-51.12%
Return on Assets [ROA]ROA -30.38%-23.52%-26.95%-28.36%-51.98%-56.49%-50.80%-50.42%-42.56%-44.01%
Return on Equity [ROE]ROE -90.66%-24.38%-28.23%-30.08%-55.39%-60.56%-54.57%-54.33%-46.02%-47.40%

ArriVent BioPharma Ratios API

Pull ArriVent BioPharma's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=AVBP&statement=Ratios&frequency=Quarter&period=all&api_key=YOUR_API_KEY